Literature DB >> 10423058

Is the esophageal squamous epithelial barrier function impaired in patients with gastroesophageal reflux disease?

R Carlsson1, L Fändriks, C Jönsson, L Lundell, R C Orlando.   

Abstract

BACKGROUND: A disturbed epithelial barrier function has been promoted as one factor in the pathogenesis of gastroesophageal reflux disease (GERD). We therefore studied the effect of acid perfusion on the transmural potential difference (PD) of the distal esophagus in relation to onset of reflux symptoms.
METHODS: PD was assessed during perfusion with saline and with 0.1 M HCl in healthy controls (n = 17) and in GERD patients without (n = 15) or with esophagitis (n = 6) and in remission after a fundoplication (n = 10). Heartburn and other upper GI symptoms were recorded concomitantly. Endoscopy-negative patients were studied before and after omeprazole treatment.
RESULTS: HCl perfusion induced more lumennegative peak PD values in patients with active GERD, regardless of the presence or absence of esophagitis, than in healthy controls. After successful therapy, the PD response to acid perfusion equalled that of healthy subjects. Acid perfusion was associated with the onset of heartburn in most patients with active GERD but in none of the healthy subjects, and less frequently after medical and surgical therapy.
CONCLUSIONS: The epithelial permeability to hydrogen ions differs between healthy subjects and patients with active GERD. Effective treatment, such as omeprazole or fundoplication, might improve the barrier function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10423058     DOI: 10.1080/003655299750026155

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

Review 1.  Endoscopy-negative reflux disease.

Authors:  J P Galmiche; S B des Varannes
Journal:  Curr Gastroenterol Rep       Date:  2001-06

2.  Esophageal mucosal sensitivity: possible links with clinical presentations in patients with erosive esophagitis and laryngopharyngeal reflux.

Authors:  Murat Korkmaz; Erkan Tarhan; Hakan Unal; Haldun Selcuk; Ugur Yilmaz; Levent Ozluoglu
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

3.  Acid challenge to the esophageal mucosa: effects on local nitric oxide formation and its relation to epithelial functions.

Authors:  Mogens Bove; Michael Vieth; Anna Casselbrant; Lars Ny; Lars Lundell; Magnus Ruth
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

4.  Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis.

Authors:  Carine Blanchard; Emily M Stucke; Karen Burwinkel; Julie M Caldwell; Margaret H Collins; Annette Ahrens; Bridget K Buckmeier; Sean C Jameson; Allison Greenberg; Ajay Kaul; James P Franciosi; Jonathan P Kushner; Lisa J Martin; Philip E Putnam; J Pablo Abonia; Suzanne I Wells; Marc E Rothenberg
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

5.  Brain activity following esophageal acid infusion using positron emission tomography.

Authors:  Shigeyuki Kobayashi; Yasuhiko Abe; Manabu Tashiro; Tomoyuki Koike; Katsunori Iijima; Akira Imatani; Shuichi Ohara; Satoshi Watanabe; Shin Fukudo; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

6.  Regulation of Na/H exchanger-1 in gastroesophageal reflux disease: possible interaction of histamine receptor.

Authors:  I Siddique; I Khan
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

7.  Stress-related changes in oesophageal permeability: filling the gaps of GORD?

Authors:  Johan D Söderholm
Journal:  Gut       Date:  2007-04-20       Impact factor: 23.059

8.  Gastroesophageal reflux activates the NF-κB pathway and impairs esophageal barrier function in mice.

Authors:  Yu Fang; Hao Chen; Yuhui Hu; Zorka Djukic; Whitney Tevebaugh; Nicholas J Shaheen; Roy C Orlando; Jianguo Hu; Xiaoxin Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-02       Impact factor: 4.052

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.